Olema Pharmaceuticals, Inc. · NASDAQ:OLMA
BlackRock, Inc. reported a 7.10% stake in Olema Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc. reported a 7.10% stake in Olema Pharmaceuticals, Inc., 6,244,212 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G/A).
- Stake
- 7.10%
- Shares
- 6,244,212
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.10% | 6,244,212 |
Source
Related
- Olema Pharmaceuticals, Inc.
- BlackRock, Inc.
- Olema Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Bvf Partners L P · Oct 16, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Form 4 · Harmon Cyrus · Jul 27, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026